Učitavanje...
Cardiotoxicity of the new cancer therapeutics- mechanisms of, and approaches to, the problem
Cardiotoxicity of some targeted therapeutics, including monoclonal antibodies and small molecule inhibitors, is a reality. Herein we will examine why it occurs, focusing on molecular mechanisms to better understand the issue. We will also examine how big the problem is and, more importantly, how big...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2008
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2735339/ https://ncbi.nlm.nih.gov/pubmed/18617014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2008.05.011 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|